journal article·2026-12

Base-mediated multi-component reaction to optimize anthracene-conjugated dicyanopyridines as heavy-atom-free photosensitizers for photodynamic therapy

Xin Zhou, Ming Liu, Kun Tang, Zhong-Qiu Li, Xiao-Xiong Wu, Tongling Liang, Si-Hai Wu, Yu-Wu Zhong, Jian-Hong Tang

Dyes and Pigments· Volume 255
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Radical Photochemical Reactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
2. Recent advances in organelle-targeted organic photosensitizers for efficient photodynamic therapy10.1016/j.ccr.2024.215710 ↗
3. From low to no O2-dependent hypoxia photodynamic therapy (hPDT): a new perspective10.1021/acs.accounts.2c00531 ↗
4. Enhancing biosafety in photodynamic therapy: progress and perspectives10.1039/D5CS00054H ↗
5. Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies10.1039/D3SC07006A ↗
6. Recent advances in noble metal complex based photodynamic therapy10.1039/D1SC05478C ↗
7. Development of geometry-controlled all-orthogonal BODIPY trimers for photodynamic therapy and phototheragnosis10.1021/acs.orglett.2c01169 ↗
8. Photoredox catalysis may be a general mechanism in photodynamic therapy
9. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
10. Strategic construction of sulfur-bridged BODIPY dimers and oligomers as heavy-atom-free photosensitizers10.1021/acs.orglett.1c02622 ↗
11. Twisted bodipy derivative as a heavy-atom-free triplet photosensitizer showing strong absorption of yellow light, intersystem crossing, and a high-energy long-lived triplet state10.1021/acs.orglett.0c01903 ↗
12. Site-selected thionated benzothioxanthene chromophores as heavy-atom-free small-molecule photosensitizers for photodynamic therapy10.1038/s42004-022-00752-x ↗
13. Organic photosensitizers: from molecular design to phototheranostics10.1039/D5CS00599J ↗
14. Smart molecular designs and applications of activatable organic photosensitizers10.1038/s41570-024-00662-7 ↗
15. Thionated perylenebisimides as heavy‐atom‐free triplet photosensitizers: intersystem crossing, electron spin dynamics, and application in photodynamic therapy
16. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer10.1021/acs.accounts.0c00606 ↗
17. Heavy‐atom‐free supramolecular photosensitizers derived from conventional fluorophores10.1002/anie.202508968 ↗
18. Electronic relaxation pathways in heavy-atom-free photosensitizers absorbing near-infrared radiation and exhibiting high yields of singlet oxygen generation10.1021/jacs.0c13203 ↗
19. Supramolecular assembly of a heavy‐atom‐free highly efficient self‐deliverable photosensitizer for activable photodynamic therapy
20. Molecular design of highly efficient heavy‐atom‐free near‐infrared cyanine photosensitizers for fluorescence image‐guided photodynamic therapy of solid tumors10.1002/adhm.202505692 ↗
21. Anthracene‐Based endoperoxides as self‐sensitized singlet oxygen carriers for hypoxic‐tumor photodynamic therapy10.1002/adhm.202403009 ↗
22. Singlet oxygen “afterglow” therapy with NIR‐II fluorescent molecules10.1002/adma.202103627 ↗
23. An approach to developing cyanines with simultaneous intersystem crossing enhancement and excited-state lifetime elongation for photodynamic antitumor metastasis10.1021/jacs.1c06275 ↗
24. An anthracene-based molecular rotor as a theranostic agent for viscosity sensing and imaging-guided photodynamic therapy10.1039/D5TB02822A ↗
25. Long-acting fractionated sonodynamic therapy enabled by fused-trianthracene nanoparticles with ultra-bright ultrasound-induced afterglow luminescence
26. Enhancing fractionated cancer therapy: a triple-anthracene photosensitizer unleashes long-persistent photodynamic and luminous efficacy10.1021/jacs.3c14387 ↗
27. Anthracene-bridged photosensitizers for effective and safe photodynamic therapy10.1021/acs.chemmater.2c03274 ↗
28. Modifications on the amino-3, 5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity10.1021/acs.jmedchem.9b00106 ↗
29. The aminopyridine-3, 5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor10.1016/j.ejmech.2018.02.081 ↗
30. An impact of the aryl substituent in position 4 of dicyanopyridines on efficiency of thermally activated delayed fluorescence and electroluminescence10.1016/j.optmat.2025.117027 ↗
31. Rational design of highly efficient Orange‐Red/Red thermally activated delayed fluorescence emitters with submicrosecond emission lifetimes10.1002/advs.202300808 ↗
32. 3, 5-Dicyanopyridine motifs for electron-transporting semiconductors: from design and synthesis to efficient organic light-emitting diodes10.1039/D3TC00841J ↗
33. Structural investigation, hirshfeld surface analysis and quantum mechanical study of two dicyanopyridine derivatives10.1016/j.molstruc.2020.129748 ↗
34. Achieving ultralong-lived flexible room-temperature phosphorescence, detection of strain and photostability, and high-level data encryption based on benzophenone derivatives10.1016/j.cej.2025.165087 ↗
35. Modulating the acceptor structure of dicyanopyridine based TADF emitters: nearly 30% external quantum efficiency and suppression on efficiency roll-off in OLED10.1016/j.cej.2020.126107 ↗
36. Efficient yellow thermally activated delayed fluorescent emitters based on 3, 5-dicyanopyridine acceptors10.1021/acs.jpcc.0c08430 ↗
37. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia10.1038/s43018-021-00249-x ↗
38. Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors10.1016/j.str.2022.03.009 ↗
39. Synthesis, optical properties of multi donor–acceptor substituted AIE pyridine derivatives dyes and application for Au3+ detection in aqueous solution10.1016/j.dyepig.2015.01.005 ↗
40. Detection of reactive oxygen species associated with photodynamic therapy10.1039/D6CC00750C ↗